TIF urges patient-centred thalassaemia policies in 2025 review
The International Thalassaemia Federation says a global appeal developed with the Cyprus government seeks stronger national action and a greater role for patients.
Nicosia, Cyprus. The International Thalassaemia Federation (TIF) said in its 2025 annual review that a global appeal developed jointly with the Cyprus government provides political guidance and promotes stronger national action on hemoglobinopathies.
Public health priority and patient involvement
According to TIF, the appeal was presented at a high-level gathering in Cyprus marking World Thalassaemia Day. It urged governments and partners to treat thalassaemia as a priority for public health and give patients a central role in decisions concerning their care and future.
Scientific progress and continuing care needs
The federation described 2025 as a year of hope and greater responsibility, saying scientific progress over the previous decade had expanded the possibilities available to people with thalassaemia.
“However, the reality of daily care reminds us that much has yet to be done,” it said.
TIF said it would maintain its efforts to promote equitable access to care and new treatments, strengthen training and collaboration, and help improve healthcare and social welfare systems so they can respond to patients’ needs.
This news item was generated automatically by Cyprus Inform from publicly available materials. Report an error →